Poupon RE - Search Results

1

Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study.

Serfaty L, Chazouillères O, Poujol-Robert A, Morand-Joubert L, Dubois C, Chrétien Y, Poupon RE, Petit JC, Poupon R. Serfaty L, et al. Among authors: poupon re, poupon r. Hepatology. 1997 Sep;26(3):776-9. doi: 10.1002/hep.510260334. Hepatology. 1997. PMID: 9303512

2

Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C.

Guéchot J, Poupon RE, Giral P, Balkau B, Giboudeau J, Poupon R. Guéchot J, et al. Among authors: poupon re, poupon r. J Hepatol. 1994 Mar;20(3):388-93. doi: 10.1016/s0168-8278(94)80013-8. J Hepatol. 1994. PMID: 8014451

3

Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy.

Poupon RE, Chrétien Y, Poupon R, Paumgartner G. Poupon RE, et al. Among authors: poupon r. Hepatology. 1993 Apr;17(4):599-604. doi: 10.1002/hep.1840170412. Hepatology. 1993. PMID: 8477964 Clinical Trial.

4

Determinants of outcome of compensated hepatitis C virus-related cirrhosis.

Serfaty L, Aumaître H, Chazouillères O, Bonnand AM, Rosmorduc O, Poupon RE, Poupon R. Serfaty L, et al. Among authors: poupon re, poupon r. Hepatology. 1998 May;27(5):1435-40. doi: 10.1002/hep.510270535. Hepatology. 1998. PMID: 9581703

5

Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group.

Poupon RE, Bonnand AM, Chrétien Y, Poupon R. Poupon RE, et al. Among authors: poupon r. Hepatology. 1999 Jun;29(6):1668-71. doi: 10.1002/hep.510290603. Hepatology. 1999. PMID: 10347106 Clinical Trial.

6

Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis.

Guéchot J, Serfaty L, Bonnand AM, Chazouillères O, Poupon RE, Poupon R. Guéchot J, et al. Among authors: poupon re, poupon r. J Hepatol. 2000 Mar;32(3):447-52. doi: 10.1016/s0168-8278(00)80396-7. J Hepatol. 2000. PMID: 10735615

7

Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis?

Corpechot C, Benlian P, Barbu V, Chazouillères O, Poupon RE, Poupon R. Corpechot C, et al. Among authors: poupon re, poupon r. J Hepatol. 2001 Sep;35(3):324-8. doi: 10.1016/s0168-8278(01)00137-4. J Hepatol. 2001. PMID: 11592592

8

Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group.

Poupon RE, Eschwège E, Poupon R. Poupon RE, et al. Among authors: poupon r. J Hepatol. 1990 Jul;11(1):16-21. doi: 10.1016/0168-8278(90)90265-s. J Hepatol. 1990. PMID: 1975819 Clinical Trial.

9

Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo.

Andreani T, Poupon RE, Balkau BJ, Trinchet JC, Grange JD, Peigney N, Beaugrand M, Poupon R. Andreani T, et al. Among authors: poupon re, poupon r. Hepatology. 1990 Dec;12(6):1413-9. doi: 10.1002/hep.1840120624. Hepatology. 1990. PMID: 2258157 Clinical Trial.

10

Serum hyaluronan as a marker of liver fibrosis.

Guéchot J, Poupon RE, Poupon R. Guéchot J, et al. Among authors: poupon re, poupon r. J Hepatol. 1995;22(2 Suppl):103-6. J Hepatol. 1995. PMID: 7665843 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters